FDA Drafts New Rules for Safer Blood Hepatitis B Checks
Published Date: 7/16/2025
Notice
Summary
The FDA just shared new draft advice for blood centers on how to test donations for hepatitis B to keep blood safer. This update affects anyone who collects whole blood or plasma and aims to replace old testing rules from 2012 and 1987. Blood centers should get ready for these changes, which could improve safety without adding big costs or delays.
Analyzed Economic Effects
1 provisions identified: 1 benefits, 0 costs, 0 mixed.
New FDA Hepatitis B Testing Guidance
If you collect whole blood or blood components (including Source Plasma), the FDA has issued a draft guidance with recommendations for testing donations for hepatitis B surface antigen (HBsAg). The draft guidance, when finalized, is intended to supersede the October 2012 guidance and the December 1987 memorandum on HBsAg testing to reduce the risk of transfusion-transmitted hepatitis B virus (HBV).
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Take It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in